Ftse Mib
33.766,29
-0,06%
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
1,03%
Bitcoin
96.063,04
-1,18%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ AMAG Pharmaceuticals Inc (AMAG) AMAG Pharmaceuticals Inc (AMAG) Notizie

AMAG

AMAG Pharmaceuticals (AMAG)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AMAG
DataOraFonteTitoloSimboloCompagnia
16/02/202122:39Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AMAGAMAG Pharmaceuticals Inc
14/12/202014:47GlobeNewswire Inc.AMAG Pharmaceuticals Files Submission in Response To the Food And Drug Administration’s Notice of Opportunity for a Hearing...NASDAQ:AMAGAMAG Pharmaceuticals Inc
27/11/202015:09Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:AMAGAMAG Pharmaceuticals Inc
24/11/202012:05Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AMAGAMAG Pharmaceuticals Inc
24/11/202012:01Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:AMAGAMAG Pharmaceuticals Inc
17/11/202021:47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMAGAMAG Pharmaceuticals Inc
17/11/202012:00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AMAGAMAG Pharmaceuticals Inc
16/11/202022:40Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AMAGAMAG Pharmaceuticals Inc
16/11/202022:30Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:AMAGAMAG Pharmaceuticals Inc
16/11/202015:27Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:AMAGAMAG Pharmaceuticals Inc
16/11/202015:25PR Newswire (US)Covis Group Completes Acquisition of AMAG PharmaceuticalsNASDAQ:AMAGAMAG Pharmaceuticals Inc
13/11/202014:30Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:AMAGAMAG Pharmaceuticals Inc
06/11/202022:18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AMAGAMAG Pharmaceuticals Inc
06/11/202000:40PR Newswire (US)MGIC Investment & Halozyme Therapeutics Set to Join S&P MidCap 400; First Bancorp, The Geo Group & Mednax to Join S&P SmallCa...NASDAQ:AMAGAMAG Pharmaceuticals Inc
15/10/202014:44Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:AMAGAMAG Pharmaceuticals Inc
15/10/202013:30PR Newswire (Canada)Covis Group S.à r.l. Announces Commencement of Tender Offer for All Outstanding Shares of AMAG Pharmaceuticals, Inc.NASDAQ:AMAGAMAG Pharmaceuticals Inc
15/10/202013:23Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:AMAGAMAG Pharmaceuticals Inc
14/10/202022:11GlobeNewswire Inc.AMAG Pharmaceuticals Requests Hearing to Maintain Makena® (Hydroxyprogesterone Caproate Injection) as a Treatment Option for...NASDAQ:AMAGAMAG Pharmaceuticals Inc
13/10/202022:37Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:AMAGAMAG Pharmaceuticals Inc
06/10/202003:05GlobeNewswire Inc.AMAG Pharmaceuticals Provides Update on FDA’s Proposal Regarding Makena® (Hydroxyprogesterone Caproate Injection)NASDAQ:AMAGAMAG Pharmaceuticals Inc
02/10/202019:02PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of AMAG Pharmaceuticals, Inc.NASDAQ:AMAGAMAG Pharmaceuticals Inc
01/10/202023:21Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:AMAGAMAG Pharmaceuticals Inc
01/10/202016:45GlobeNewswire Inc.Covis Group Announces Agreement to Acquire AMAG PharmaceuticalsNASDAQ:AMAGAMAG Pharmaceuticals Inc
15/09/202023:17Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:AMAGAMAG Pharmaceuticals Inc
15/09/202022:07Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:AMAGAMAG Pharmaceuticals Inc
09/09/202014:00GlobeNewswire Inc.AMAG Pharmaceuticals to Participate in H.C. Wainwright 22nd Annual Global Investment ConferenceNASDAQ:AMAGAMAG Pharmaceuticals Inc
06/08/202013:00GlobeNewswire Inc.AMAG Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Corporate UpdateNASDAQ:AMAGAMAG Pharmaceuticals Inc
28/07/202014:00GlobeNewswire Inc.AMAG Pharmaceuticals to Host Second Quarter FY 2020 Financial Results Conference Call and Webcast on Thursday, August 6, 202...NASDAQ:AMAGAMAG Pharmaceuticals Inc
27/07/202013:30GlobeNewswire Inc.AMAG Pharmaceuticals Completes Divestment of Women’s Health AssetsNASDAQ:AMAGAMAG Pharmaceuticals Inc
23/07/202015:01PR Newswire (US)AMAG Pharmaceuticals and Norgine B.V. Enter Into Exclusive Licensing Agreement to Commercialize Ciraparantag in Europe, Austr...NASDAQ:AMAGAMAG Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AMAG

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENI
Eni
BIT
STLAM
Stellantis NV
BIT
SPM
Saipem
BIT
ENEL
Enel
BIT
TIT
Telecom Italia
BIT
RACE
Ferrari NV
BIT
STMMI
ST Microelectronics
BIT
BAMI
Banco BPM
BIT
BPE
Bper Banca
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
PRY
Prysmian
BIT
TEN
Tenaris
BIT
MONC
Moncler
BIT
FBK
Finecobank
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network